ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Outcomes of Liver Grafts from Donors with Very High Transaminases.

P. Martins, A. Rawson, P. Mahboub, B. Movahedi, N. Dolgin, I. Bruggenwirth, A. Bozorgzadeh.

Department of Surgery, Transplant Division, University of Massachusetts, Worcester, MA.

Meeting: 2016 American Transplant Congress

Abstract number: D121

Keywords: Donors, Ischemia, Liver transplantation, marginal, Outcome

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Ischemia Reperfusion Injury: Clinical Update

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Increased Utilization of High Risk Deceased Donors with Share 35 Does Not Affect Outcomes in Liver Transplantation.
  • Kidneys from Living Donors With High Body Mass Index Do Not Have Inferior Outcomes

Introduction: Traditionally, elevation of transaminases has been broadly used as markers of hepatic ischemic injury and crucial parameters for liver graft assessment. We wanted to assess if the outcomes of grafts from donors with high transaminases were inferior.

Methods: We retrospectively review the medical records of all primary liver transplants (n= 425) performed at UMass Medical Center between 1998 and 2013 using brain dead donors. 14 patients received livers from donors with AST or ALT>1,000U/L (HighTrans group) while 411 received from donors with AST/ALT lower than 1,000U/L (LowTrans group).

Results: When we compared donors from the high transaminase group with the low transaminase group there were no major differences in donor and recipient demographics. The peak of AST and ALT happened in the first 24 hours after the admission of the donor and significantly decreased at the day of procurement. The liver function tests of recipients of the HighTrans group normalized within the first week. The rate of primary non function, initial poor function, hepatic artery thrombosis, and use of blood products were similar. The graft and patient survival were similar (75% vs. 80%. 3 year graft survival p=0.48), and 72% vs. 82% 3-year patient survival, p=0.33).

Conclusions: We showed that selected liver grafts from donors with very high AST/ALT levels can be safely used. Judicious selection of these grafts, by eliminating additional risks factors, and adequate recipient matching are crucial to obtain acceptable outcomes.

CITATION INFORMATION: Martins P, Rawson A, Mahboub P, Movahedi B, Dolgin N, Bruggenwirth I, Bozorgzadeh A. Outcomes of Liver Grafts from Donors with Very High Transaminases. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Martins P, Rawson A, Mahboub P, Movahedi B, Dolgin N, Bruggenwirth I, Bozorgzadeh A. Outcomes of Liver Grafts from Donors with Very High Transaminases. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-liver-grafts-from-donors-with-very-high-transaminases/. Accessed February 26, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Penis Transplantation: First U.S. Experience.
      • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
      • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
      • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
      • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

      Visit Our Partner Sites

      American Transplant Congress (ATC)

      Visit the official site for the American Transplant Congress »

      American Journal of Transplantation

      The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

      American Society of Transplantation (AST)

      An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

      American Society of Transplant Surgeons (ASTS)

      The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

      Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

      Privacy Policy

      loading Cancel
      Post was not sent - check your email addresses!
      Email check failed, please try again
      Sorry, your blog cannot share posts by email.
      This site uses cookies: Find out more.